Détails sur le projet
Description
ARO-ENAC is being developed to treat people with Cystic Fibrosis by blocking the expression of a protein which may lead to improved mucus hydration and clearance and may prevent further lung injury.
| Statut | Terminé |
|---|---|
| Date de début/de fin réelle | 10/1/01 → 12/1/21 |
Financement
- Social Sciences and Humanities Research Council of Canada: 5 811 707,00 $ US
ASJC Scopus Subject Areas
- Genetics(clinical)
- Pulmonary and Respiratory Medicine
- Pharmacology
- Medicine(all)
- Organic Chemistry
- Renewable Energy, Sustainability and the Environment